Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Total Debt (2018 - 2025)

Exagen (XGN) has disclosed Total Debt for 8 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 13.15% year-over-year to $22.9 million, compared with a TTM value of $22.9 million through Dec 2025, up 13.15%, and an annual FY2025 reading of $22.9 million, up 13.15% over the prior year.
  • Total Debt was $22.9 million for Q4 2025 at Exagen, roughly flat from $22.9 million in the prior quarter.
  • Across five years, Total Debt topped out at $29.3 million in Q1 2023 and bottomed at $19.4 million in Q2 2023.
  • Average Total Debt over 5 years is $23.9 million, with a median of $23.0 million recorded in 2025.
  • The sharpest move saw Total Debt tumbled 33.43% in 2024, then increased 13.45% in 2025.
  • Year by year, Total Debt stood at $27.5 million in 2021, then grew by 5.42% to $29.0 million in 2022, then plummeted by 32.7% to $19.5 million in 2023, then increased by 3.85% to $20.2 million in 2024, then grew by 13.15% to $22.9 million in 2025.
  • Business Quant data shows Total Debt for XGN at $22.9 million in Q4 2025, $22.9 million in Q3 2025, and $23.0 million in Q2 2025.